Compare Simon Property Group Inc (SPG) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Simon Property Group Inc vs Tenet Healthcare Corporation — how do they compare? Simon Property Group Inc trades at $219.28 (market cap $71.52B), while Tenet Healthcare Corporation trades at $259.45 (market cap $20.93B). The key difference: Simon Property Group Inc is far larger — about 3.4× Tenet Healthcare Corporation's market cap, and Simon Property Group Inc pays a 3.99% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| SPG | THC | |
|---|---|---|
Market Cap | $71.52B | $20.93B |
Sector | Real Estate | Health |
52-Week High | $236.70 | $262.63 |
52-Week Low | $169.22 | $161.37 |
Enterprise Value | $100.00B | $32.01B |
Dividend Yield | 3.99% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Simon Property Group (SPG) trades at $222.91, up 0.49% on the day, near its consensus price target of $223.50. The stock shows strong fundamentals with a P/E of 15.5 and robust profitability, including a net income margin of 70.59% and ROE of 127.05%. Recent Q2 2026 earnings beat expectations with FFO of $3.29 per share, driven by leasing momentum and raised guidance. Technical indicators are bearish overall, with support at $221 and resistance at $224. The company maintains a solid dividend, paying $2.25 in H1 2026.
Outlook: SPG benefits from strong operational performance and raised 2026 guidance, supported by tenant demand and property NOI growth. Investment opportunities include consistent earnings beats and a high ROE. Risks involve elevated long-term debt of $24.21 billion, potential interest rate pressures, and e-commerce competition. Analyst sentiment is mixed with 40.54% buy ratings, but technical bearish signals suggest near-term caution.
Tenet Healthcare (THC) trades at $262.13, up 2.14% with strong technical momentum and bullish analyst sentiment. The stock shows robust fundamentals with Q2 2026 EPS beating estimates at $6.12 versus $4.26 expected, while valuation metrics remain attractive with P/E of 10.05 and EV/EBITDA of 5.74. Recent institutional buying and positive earnings revisions support the upward trend.
Outlook remains positive with consensus price target of $281.44 offering 7.4% upside potential. Key risks include healthcare policy headwinds and competitive pressures, but strong ambulatory growth and expense management provide fundamental support. The stock presents a compelling value-growth combination for investors seeking healthcare exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Simon Property Group Inc
Simon Property Group is the second- largest real estate investment trust in the United States. Its portfolio includes an interest in 207 properties: 119 traditional malls, 69 premium outlets, 14 Mills centers (a combination of a traditional mall, outlet center, and big-box retailers), six lifestyle centers, and five other retail properties. Simon's portfolio averaged $693 in sales per square foot over the 12 months prior to the pandemic. The company also owns a 21% interest in Klepierre, a European retail company with investments in shopping centers in 16 countries, and joint venture interests in 33 premium outlets across 11 countries.
Read more on SPG →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
